THE events of the past 2 yr since the initial controversial publication by Mangano et al. regarding the effect of aprotinin on renal failure and mortality have been of great interest to the anesthesiology community. In this issue of ANESTHESIOLOGY, Dietrich et al. test the hypothesis that any potential nephrotoxic effect of aprotinin (Bayer Healthcare Inc., Toronto, Ontario, Canada) is dose dep...
